Differential Role of Factor XIII in Acute Myocardial Infarction and Ischemic Stroke

Factor XIII is a transglutaminase enzyme that plays a crucial role in hemostasis and wound healing. It crosslinks fibrin strands, stabilizing clots and promoting clot resistance to fibrinolysis. Additionally, Factor XIII has been found to have multiple other functions that extend beyond coagulation,...

Full description

Bibliographic Details
Main Authors: Jan Traub, Martin S. Weber, Anna Frey
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/12/3/497
_version_ 1827306944143032320
author Jan Traub
Martin S. Weber
Anna Frey
author_facet Jan Traub
Martin S. Weber
Anna Frey
author_sort Jan Traub
collection DOAJ
description Factor XIII is a transglutaminase enzyme that plays a crucial role in hemostasis and wound healing. It crosslinks fibrin strands, stabilizing clots and promoting clot resistance to fibrinolysis. Additionally, Factor XIII has been found to have multiple other functions that extend beyond coagulation, including the regulation of inflammation and tissue repair processes. Emerging evidence suggests that Factor XIII may also have differential roles in acute myocardial infarction and ischemic stroke, two common cardiovascular events with significant morbidity and mortality. In acute myocardial infarction, Factor XIII has been implicated in promoting clot stability and reducing the risk of re-occlusion. In ischemic stroke, Factor XIII may also contribute to the pathogenesis of cerebral ischemia by promoting clot formation and exacerbating neuronal damage. Several studies have investigated the association between Factor XIII and these cardiovascular events, using various approaches such as genetic polymorphism analysis, animal models, and clinical data analysis. These studies have provided important insights into the role of Factor XIII in acute myocardial infarction and ischemic stroke, highlighting its potential as a therapeutic target for interventions aimed at improving outcomes in these conditions. In this review, we will summarize the current understanding of Factor XIII’s role in acute myocardial infarction and ischemic stroke.
first_indexed 2024-04-24T18:32:05Z
format Article
id doaj.art-315dfd91ff604adcb2a997c0340e52e5
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-04-24T18:32:05Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-315dfd91ff604adcb2a997c0340e52e52024-03-27T13:22:33ZengMDPI AGBiomedicines2227-90592024-02-0112349710.3390/biomedicines12030497Differential Role of Factor XIII in Acute Myocardial Infarction and Ischemic StrokeJan Traub0Martin S. Weber1Anna Frey2Department of Internal Medicine I, University Hospital Würzburg, 97080 Würzburg, GermanyDepartment of Neurology, University Hospital Göttingen, 37075 Göttingen, GermanyDepartment of Internal Medicine I, University Hospital Würzburg, 97080 Würzburg, GermanyFactor XIII is a transglutaminase enzyme that plays a crucial role in hemostasis and wound healing. It crosslinks fibrin strands, stabilizing clots and promoting clot resistance to fibrinolysis. Additionally, Factor XIII has been found to have multiple other functions that extend beyond coagulation, including the regulation of inflammation and tissue repair processes. Emerging evidence suggests that Factor XIII may also have differential roles in acute myocardial infarction and ischemic stroke, two common cardiovascular events with significant morbidity and mortality. In acute myocardial infarction, Factor XIII has been implicated in promoting clot stability and reducing the risk of re-occlusion. In ischemic stroke, Factor XIII may also contribute to the pathogenesis of cerebral ischemia by promoting clot formation and exacerbating neuronal damage. Several studies have investigated the association between Factor XIII and these cardiovascular events, using various approaches such as genetic polymorphism analysis, animal models, and clinical data analysis. These studies have provided important insights into the role of Factor XIII in acute myocardial infarction and ischemic stroke, highlighting its potential as a therapeutic target for interventions aimed at improving outcomes in these conditions. In this review, we will summarize the current understanding of Factor XIII’s role in acute myocardial infarction and ischemic stroke.https://www.mdpi.com/2227-9059/12/3/497factor XIIIfibrin stabilizing factoracute myocardial infarctionischemic strokemortalitybiomarker
spellingShingle Jan Traub
Martin S. Weber
Anna Frey
Differential Role of Factor XIII in Acute Myocardial Infarction and Ischemic Stroke
Biomedicines
factor XIII
fibrin stabilizing factor
acute myocardial infarction
ischemic stroke
mortality
biomarker
title Differential Role of Factor XIII in Acute Myocardial Infarction and Ischemic Stroke
title_full Differential Role of Factor XIII in Acute Myocardial Infarction and Ischemic Stroke
title_fullStr Differential Role of Factor XIII in Acute Myocardial Infarction and Ischemic Stroke
title_full_unstemmed Differential Role of Factor XIII in Acute Myocardial Infarction and Ischemic Stroke
title_short Differential Role of Factor XIII in Acute Myocardial Infarction and Ischemic Stroke
title_sort differential role of factor xiii in acute myocardial infarction and ischemic stroke
topic factor XIII
fibrin stabilizing factor
acute myocardial infarction
ischemic stroke
mortality
biomarker
url https://www.mdpi.com/2227-9059/12/3/497
work_keys_str_mv AT jantraub differentialroleoffactorxiiiinacutemyocardialinfarctionandischemicstroke
AT martinsweber differentialroleoffactorxiiiinacutemyocardialinfarctionandischemicstroke
AT annafrey differentialroleoffactorxiiiinacutemyocardialinfarctionandischemicstroke